Condition
ACS (Acute Coronary Syndrome) clinical trials and research
As of November 12, 2026, Find a Trial lists 10 ACS (Acute Coronary Syndrome) clinical trials that are recruiting, at sites in 7 countries (most in China (4), Switzerland (1), France (1)). By phase: Phase 4 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 7Countries
Newest ACS (Acute Coronary Syndrome) clinical trials
All recruiting trials (10)
-
EHR-guided LDL cholesterol optimization after a heart event
A pharmacist-guided program using electronic health records to help adults in Alberta reach LDL goals after a heart event by adjusting medications and ordering tests.
-
Lying‑Sitting‑Standing Baduanjin to improve heart and lung function in acute coronary syndrome with heart failure
This study will test whether a gentle sequence of Baduanjin exercises performed lying, sitting, and standing helps people hospitalized with acute coronary syndrome and heart failure improve heart and lung function and quality of life.
-
Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS
This trial tests whether daily dapagliflozin can lower heart artery inflammation and slow plaque growth in adults with stage 4 CKM syndrome after acute coronary syndrome.
-
EuroHeart Italy registry for acute coronary syndrome, heart failure, and atrial fibrillation
This project will collect health information to see if following ESC quality indicators improves care for adults treated for acute coronary syndrome, heart failure, or atrial fibrillation.
-
Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.
This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.
-
Cardiovascular problems after allogeneic stem cell transplant
This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.
-
Cardiac rehabilitation cohort at Medicine Campus Davos to explore recovery
This project will follow adults coming to Hochgebirgsklinik Davos for cardiac rehabilitation to see how their heart health and recovery progress over time.
-
Multi-omics analysis of colchicine effects in acute coronary syndrome patients
This project will try to see if daily low-dose colchicine reduces inflammation and to find biological markers that predict who benefits among people with acute coronary syndrome.
-
Targeted look at residual inflammation after a heart attack
This project will test whether the neutrophil-to-lymphocyte ratio (NLR) from the first routine blood draw can help predict risk of death in adults (18–85) after an acute coronary syndrome treated with PCI.
-
Genotype-guided selection of P2Y12 inhibitors after complex heart procedures
This study is testing if choosing heart medication based on a person's genes can help people with acute coronary syndrome feel better after complex heart procedures while reducing side effects.
Related topics
Quick answers
How many ACS (Acute Coronary Syndrome) clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in China (4 trials), Switzerland (1 trial), France (1 trial), Canada (1 trial), Albania (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.